A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. - Wikidata - awgldk - TriplyDB

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

http://www.wikidata.org/entity/Q34381237

about

Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure Adenosine monophosphate-activated protein kinase in diabetic nephropathy Genetics of Insulin Resistance and the Metabolic Syndrome Influence of Acute and Chronic Exercise on Glucose Uptake Adiponectin signaling and function in insulin target tissues Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity Insulin resistance in clinical and experimental alcoholic liver disease Adipokines - removing road blocks to obesity and diabetes therapy Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer Aging and adipose tissue: potential interventions for diabetes and regenerative medicine The cell biology of fat expansion Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.Aging and caloric restriction impact adipose tissue, adiponectin, and circulating lipids Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.Adiponectin regulates contextual fear extinction and intrinsic excitability of dentate gyrus granule neurons through AdipoR2 receptors.Differential adiponectin signalling couples ER stress with lipid metabolism to modulate ageing in C. elegans Adiponectin/adiponectin receptor in disease and aging.New insight into adiponectin role in obesity and obesity-related diseases.Adipsin is an adipokine that improves β cell function in diabetes.Disease-Modifying Effect of Adiponectin in Model of α-Synucleinopathies Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling Development of second generation peptides modulating cellular adiponectin receptor responses.Cell Biology. Ronning after the adiponectin receptors.Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.Weight loss by Ppc-1, a novel small molecule mitochondrial uncoupler derived from slime mold Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.Adipokines as drug targets in diabetes and underlying disturbances.Possible new therapeutic approach for obesity-related diseases: Role of adiponectin receptor agonists.Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets Biomarkers of insulin sensitivity and insulin resistance: Past, present and future.Tumor expression of adiponectin receptor 2 and lethal prostate cancer Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance.Rapid Alterations in Perirenal Adipose Tissue Transcriptomic Networks with Cessation of Voluntary Running.Association between the level of circulating adiponectin and prediabetes: A meta-analysis

P2860

Q26745026-D2C3FAD2-550E-41E9-9396-F4BCAFA2581C Q26745623-96B51206-D1BC-4C08-B9D4-2DD58F63051E Q26745624-26733432-FED7-405E-9DD0-6A6DD7879DD4 Q26748964-B1FED295-17B5-4849-BF58-0DF5CEB9B804 Q26753354-AA58A3C7-152F-4F6C-92A5-0281C36D9702 Q26777180-CE1A3CCD-B7D4-458F-9BD3-1576184D9383 Q26865988-CF30EB33-031D-4A58-923C-1665C2AE982F Q26995825-2FB25D2F-1339-4D9C-B4ED-A7E6A6901AC0 Q28071957-98E27F4C-E27F-47D1-B27B-7D81BAA167D6 Q28079178-0604E259-0D88-4CCF-998E-40F556F495E1 Q28084054-56A94FEE-7375-4CB3-BA58-1E4DA9352E34 Q33597839-A5A673E8-D217-4734-A74F-3E60755C2C9F Q33638932-983C355C-DEFF-4C3F-80FA-90A7445EC2F9 Q33731321-0DBFA103-B91B-48D6-AF58-D748A9720467 Q33755566-C142E22C-229B-4A99-9B0E-2B747E0EDA4C Q33808884-C132A828-978D-4EF8-8C22-AF08E00317F5 Q33854987-A7177DF5-A83B-4247-A3E3-7D8BAA7A8DDF Q33894892-E2798D8E-4FA1-483A-B496-3B50CB9480B8 Q33914270-ED824904-6261-4FB3-BB2F-C4848C8C4D0B Q33943727-662E9B61-F3F4-4498-A0E9-E14A54E20547 Q34025740-C2B48A0D-8229-4909-AEC0-8858D507C7D6 Q34026035-1E506882-1F7B-40E0-9FD7-C905279470F7 Q34109255-F1ABBCF1-0A32-4D3C-BFFA-B11AA0C72E31 Q34217628-E9C04B23-913D-4DB4-8ED4-F12A6521D4AE Q34360125-B2720E13-7A8C-43BC-A92B-96640C09DFEC Q34393247-951D6AEA-6877-4712-85D4-57EA461E9D97 Q34485836-F7E51903-2F3F-4424-96D5-BA7301DB9457 Q34501403-7C78FFFF-AD32-4443-9D83-4760F4FC02B7 Q35039346-4438EDBC-C545-478A-A68B-BC00E074ADF0 Q35069125-8D856CE3-0481-44A7-AB03-55DA8D7135C6 Q35224775-82416E84-A8E5-4D18-A1B9-6DE64E5A1F6C Q35239541-F170A5AD-F2AE-41CC-A188-4D38C500A33B Q35415815-953649F5-21E6-4DB0-BB46-D77A197AAEA1 Q35571795-F9BA0A7C-9E25-4E53-BD55-A39AE10D9BC8 Q35603376-4AA78D4C-0EA8-4851-9FD3-4A763D9324EB Q35652813-FD6E1D9C-572C-4346-879F-6581FFD43E2C Q35784565-F02C08F3-888F-467D-B180-6FAA3A1D1090 Q35863452-C106B765-C9A1-4BCA-B3C8-BCE503B6A72D Q35871716-D58D8F7C-11FF-49B5-B0C6-A795ABFBD90A Q35879311-DD596579-4E45-4C14-A7FA-854EC80D959A

P2860

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

http://www.wikidata.org/entity/Q34381237

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@ast

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@en

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@nl

type

label

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@ast

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@en

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@nl

prefLabel

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@ast

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@en

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@nl

P1433

Q34381237-993DEA18-54E3-4F4A-A179-FCFE21572491

P1476

Q34381237-7331DC05-01D5-4B1B-99FE-D94366E2AFBE

P2093

Q34381237-07EC11B2-C423-4E3A-9721-8B25F361843E

Q34381237-16F04E5E-1E68-4849-9619-7F6D75847E2A

Q34381237-1E3D5E46-7257-422F-BBDC-F5A48822E793

Q34381237-2FF5072A-C930-46A1-94AA-8C8A4116DAAF

Q34381237-53009634-8908-485C-851E-676D6A2D31AC

Q34381237-5427EF98-A8DF-47D4-9554-41C799164A01

Q34381237-6260F9D7-035E-49D7-A760-4B13198DC1EB

Q34381237-8F72ED46-70BE-4498-A23A-358F643FEDCF

Q34381237-ACD51A0E-4EA8-4760-B27C-12BD4BF39E08

Q34381237-BDC9355F-AB22-4E61-B3AA-E9013062CB60

P2888

Q34381237-4738DACA-6C2C-4EC0-BDA9-4D008DEC1750

P304

Q34381237-725BD105-0AF5-4B2C-9360-5E5D47DB9E15

P31

Q34381237-FF5D00A5-EFCD-418D-A6BF-EB8AC575C574

P356

Q34381237-399168D8-B3BD-4DC9-BD28-1FA58E5136B4

P407

Q34381237-247F4107-0846-4115-B103-BC0E12FE8494

P433

Q34381237-451F34C9-17D1-474F-88BF-A52D90252BEB

P478

Q34381237-40FEA9F8-4FEE-404D-A3BD-A0F9491670BB

P50

Q34381237-2172E75B-01F7-4589-8CCB-22820123488C

Q34381237-32AEA677-98D0-4140-BFC0-CBF22FC9E0E9

P577

Q34381237-841F47C4-D5E1-44F4-BF89-74F033B86232

P698

Q34381237-A75FEED2-46D9-44AE-B940-C24902578D58

P921

Q34381237-EB9B7CC9-3387-45FA-9B17-6379F9D3BE26

Q34381237-F419178A-6CA1-4CF3-B3CA-AEF8CB2ED1D2

P356

P1433

P1476

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

@en

P2093

Akiko Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiroaki Tanabe

http://www.w3.org/2001/XMLSchema#string

Hitomi Ogata

http://www.w3.org/2001/XMLSchema#string

Ken-ichi Hamagami

http://www.w3.org/2001/XMLSchema#string

Koichi Matsuda

http://www.w3.org/2001/XMLSchema#string

Kumpei Tokuyama

http://www.w3.org/2001/XMLSchema#string

Mamiko Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Masato Iwabu

http://www.w3.org/2001/XMLSchema#string

Mikako Shirouzu

http://www.w3.org/2001/XMLSchema#string

Miki Okada-Iwabu

http://www.w3.org/2001/XMLSchema#string

P2888

P304

493-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE12656

http://www.w3.org/2001/XMLSchema#string

P407

P433

7477

http://www.w3.org/2001/XMLSchema#string

P478

503

http://www.w3.org/2001/XMLSchema#string

P50

Shigeyuki Yokoyama

P577

2013-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24172895

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes